Saturday , December 16 2017
Home / Managing Editor, Diabetes in Control (page 32)

Managing Editor, Diabetes in Control

Managing Editor, Diabetes in Control

Novo’s Two New Insulins

Last Friday, the FDA -- after rejecting them once -- finally approved Novo's two new Insulins, Tresiba and Ryzodeg. (See article for details.) Do you feel comfortable in recommending either to your patients? Follow the link to respond.

Read More »

InR Food

The #1 app to bring food transparency and effectively access reliable information such as the nutritive value for a variety of foodstuffs. Follow link for more information.

Read More »

Question #801

Test Your Knowledge

64-year female presents to your office for her 3-month follow-up. She has previously been diagnosed with mild diastolic heart failure, secondary to hypertension. She currently takes an ace-inhibitor and a diuretic with good control of her heart failure symptoms and hypertension. At her last visit, she had a FPG 118 mg/dl. In a subsequent conversation with her, you discussed how she has developed prediabetes and suggested lifestyle modifications. Since her last visit, she has taken up very gentle walking four times/week and has changed her diet to a more healthful one. Despite these positive changes, this visit's labs return an A1C 7.8%; her remaining labs are within normal limits. Which one of the following antihyperglycemic medication classes would you choose to initiate treatment? A. Sulfonylureas B. Biguanides C. Insulin D. Thiazolidinediones For the complete question and answer, just follow the link!

Read More »